Healthcare provider profile · identity verified

David C Benson, MD

Family Practice · PARK RAPIDS, MN · NPI 1902845456

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	499	139
Lisinopril	Lisinopril	457	137
Amlodipine Besylate	Amlodipine Besylate	393	113
Gabapentin	Gabapentin	384	80
Simvastatin	Simvastatin	379	94
Levothyroxine Sodium	Levothyroxine Sodium	360	93
Tamsulosin Hcl	Tamsulosin Hcl	323	88
Omeprazole	Omeprazole	279	77
Metoprolol Succinate	Metoprolol Succinate	273	75
Metformin Hcl	Metformin Hcl	260	72
Furosemide	Furosemide	247	71
Metoprolol Tartrate	Metoprolol Tartrate	194	55
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	180	48
Losartan Potassium	Losartan Potassium	175	53
Allopurinol	Allopurinol	169	46
Warfarin Sodium	Warfarin Sodium	160	47
Pantoprazole Sodium	Pantoprazole Sodium	158	45
Glipizide	Glipizide	153	40
Hydrochlorothiazide	Hydrochlorothiazide	147	45
Citalopram Hbr	Citalopram Hydrobromide	141	39
Potassium Chloride	Potassium Chloride	135	39
Eliquis	Apixaban	126	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	122	32
Rosuvastatin Calcium	Rosuvastatin Calcium	121	39
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	120	17
Clopidogrel	Clopidogrel Bisulfate	118	34
Trazodone Hcl	Trazodone Hcl	115	29
Triamcinolone Acetonide	Triamcinolone Acetonide	111	59
Sertraline Hcl	Sertraline Hcl	110	30
Oxycodone Hcl	Oxycodone Hcl	108	16
Tramadol Hcl	Tramadol Hcl	96	19
Albuterol Sulfate Hfa	Albuterol Sulfate	95	34
Pravastatin Sodium	Pravastatin Sodium	95	30
Atenolol	Atenolol	88	27
Ozempic	Semaglutide	87	13
Carvedilol	Carvedilol	81	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	80	24
Fluticasone Propionate	Fluticasone Propionate	80	28
Prednisone	Prednisone	77	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	18
Lorazepam	Lorazepam	72	12
Metformin Hcl Er	Metformin Hcl	72	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	71	21
Ventolin Hfa	Albuterol Sulfate	71	20
Oxybutynin Chloride	Oxybutynin Chloride	69	16
Lovastatin	Lovastatin	63	18
Duloxetine Hcl	Duloxetine Hcl	61	14
Pregabalin	Pregabalin	57	16
Doxycycline Monohydrate	Doxycycline Monohydrate	55	37
Ropinirole Hcl	Ropinirole Hcl	55	13
Alendronate Sodium	Alendronate Sodium	54	19
Famotidine	Famotidine	54	16
Alprazolam	Alprazolam	51	suppressed
Donepezil Hcl	Donepezil Hcl	51	12
Montelukast Sodium	Montelukast Sodium	51	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	51	35
Finasteride	Finasteride	48	15
Zolpidem Tartrate	Zolpidem Tartrate	48	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	45	11
Acetaminophen-Codeine	Acetaminophen With Codeine	44	suppressed
Paroxetine Hcl	Paroxetine Hcl	44	11
Jardiance	Empagliflozin	42	11
Ezetimibe	Ezetimibe	39	12
Bupropion Hcl Sr	Bupropion Hcl	38	suppressed
Azithromycin	Azithromycin	37	28
Trulicity	Dulaglutide	37	suppressed
Amoxicillin	Amoxicillin	36	25
Escitalopram Oxalate	Escitalopram Oxalate	34	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Baclofen	Baclofen	32	suppressed
Celecoxib	Celecoxib	32	11
Clonazepam	Clonazepam	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	11
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Nystatin	Nystatin	29	15
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Glipizide Er	Glipizide	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Nitroglycerin	Nitroglycerin	26	18
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Digoxin	Digoxin	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Victoza 3-Pak	Liraglutide	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Fentanyl	Fentanyl	23	suppressed
Divalproex Sodium	Divalproex Sodium	22	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	11
Sucralfate	Sucralfate	21	suppressed
Meloxicam	Meloxicam	20	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Cefuroxime	Cefuroxime Axetil	18	suppressed
Insulin Lispro	Insulin Lispro	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Naproxen	Naproxen	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Topiramate	Topiramate	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Liraglutide	Liraglutide	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Primidone	Primidone	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Verapamil Hcl	Verapamil Hcl	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error